SynthesisScientific reports2021

Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials.

Desye Gebrie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.